Detalhe da pesquisa
1.
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
Proc Natl Acad Sci U S A
; 116(19): 9318-9323, 2019 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962368
2.
Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity.
PLoS Pathog
; 13(3): e1006307, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28358927
3.
Pentamidine Is Not a Permeant but a Nanomolar Inhibitor of the Trypanosoma brucei Aquaglyceroporin-2.
PLoS Pathog
; 12(2): e1005436, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26828608
4.
Developmental regulation and extracellular release of a VSG expression-site-associated gene product from Trypanosoma brucei bloodstream forms.
J Cell Sci
; 123(Pt 19): 3401-11, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20826456
5.
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal Trypanosomiasis.
J Med Chem
; 65(7): 5606-5624, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303411
6.
Codon usage bias controls mRNA and protein abundance in trypanosomatids.
Elife
; 72018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29543155
7.
Inducible high-efficiency CRISPR-Cas9-targeted gene editing and precision base editing in African trypanosomes.
Sci Rep
; 8(1): 7960, 2018 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785042